Mariusz Skwarczynski

Mariusz Skwarczynski work focuses on nanotechnology-based approaches to vaccine adjuvants, with the potential for significant practical applications in developing novel vaccines. He has co-developed unique peptide, polymer, and liposomes-based adjuvanting systems used in vaccine development against malaria, hookworm, Group A Streptococcus, cancer and fertility vaccines.

As per January 2026:

He has published 3 books, 18 book chapters, and over 170 journal papers (~ 40 first and ~ 40 as last author, h index = 55, citations >9000), with a Field-Weighted Citation Impact of 2.14 (twice higher than the average researcher), and 29.9% of publications in last 5-years are in the top 10% of journals by CiteScore. Ranked 5th (Top 0.027% of 18,422) in the world in Subunit Vaccines (2012-2022; ExpertScape) and listed in World’s Top 2% Scientists by Stanford University in 2024, inside the top 0.35% in medicinal & biomolecular chemistry. His publications have received > 150 patent cites.

In the past 10 years, he secured $33.8M in grant funding, including $3.0M as the principle CI, $10.1M as a CI and $20.7M as the AI. He currently holds five grants as a CI: 2xNHMRC Ideas (CIA, 2024-27, $608K; CIA, 2024-27, $856K), CRE NHMRC (CIF, 2026-31, $3,000K), Synergy NHMRC (CIF, 2026-31, $5,000K), and ARC DP (CIA, 2026-30, $1,073K).

He has been invited 21 times in the last 5 years to present at international seminars and conferences,including invited lectures at National Nanotechnology Center (NANOTEC) (Bangkok, Thailand), Istituto Zooprofilattico Sperimentale del Mezzogiorno (Campania, Italy), University of Opole, (Opole, Poland), and 5th International Symposium on Synthetic Peptide as Human and Veterinary Pharmaceutical Products, (Varadero, Cuba). His work has received over 39 news articles from national and international agencies, including 11 interviews and articles in 2021 from Australia, India, Pakistan, Hungary, Kenya and New Zealand for his work on the oral hookworm vaccine.

He is the Regional Editor of Australia for Vaccines and Associate Editor for Frontiers in Pharmacology. He has organised 9 special issues in the last 5 years for journals such as Vaccines, Molecules and Frontiers in Pharmacology. Furthermore, he organised and chaired “Micro and Nanoparticles in Drug and Vaccine Delivery Symposium”, St Lucia, QLD, 3rd December 2021. He regularly reviews domestic grants, for example, 13 NHMRC Ideas grants in 2024, as well as international, for example, Austrian Science Fund, Netherlands Organisation for Scientific Research, The Wellcome Trust, Medical Research Council (UK). Peer reviews >10/year for top international journals (e.g. Nat. Commun.; Adv. Sci.; Adv. Mater.; Adv. Drug Deliv. Rev; Acta Biomater.).

He was/is co/supervisor of 33 PhD students (graduated and ongoing), and co/supervisor of over 30 research students. In the years 2019-2025, his supervised students received eleven awards, including the Dean’s Award for Outstanding Higher Degree by Research Theses, and awards at international conferences (travel, best poster, best oral presentations).